Benitec Biopharma Inc. (BNTC:NASDAQ) closed at $8.49 on November 2, 2026, down 2.86% on the day. The stock trades 47.9% below its 52-week high of $16.31 and 7.7% above its 52-week low of $7.89. Over the past year, it lost 46.5%. Benitec Biopharma Inc. is part of the Health Care sector (Major Pharmaceuticals).
In 252 trading sessions since October 31, 2025, BNTC closed higher on 119 days (47%). Its best day was March 9, 2026 (+10.67%) and its worst was November 6, 2025 (-23.95%). The stock moved 10% or more in a single session 5 times. It opened at least 5% above the previous day's high 1 time.
Benitec Biopharma Ltd is a biotechnology company which develops therapeutic technology platform that combines gene silencing and gene therapy which cures disease causing genes from single administration.
Find more stocks like BNTC with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.